Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amitriptyline and Trifluoperazine in Functional Dyspepsia
NCT07008235Phase 3Recruiting
- Start
- Jul 2025
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of amitriptyline, trifluoperazine in functional dyspepsia (FD). Started Jul 2025; status: recruiting.
02
Drugs
amitriptylinetrifluoperazine
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT07008235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07008235.